Losartan and aplastic anemia

23 Without definitive treatment, mortalityfrom severe AA (SAA) approaches 70% See full list on mayoclinic. The phase IV clinical study analyzes which people take Losartan and have Aplastic anemia

2024-03-29
    Synthroid is classified as
  1. Left untreated, aplastic anemia is a life-threatening condition
  2. 1 AA confers a significant risk for morbidity
  3. Hematopoietic stem-cell
  4. Inherited bone marrow failure syndromes – there are rare inherited
  5. Currently, eHealthMe is studying from 164,894 Losartan users
  6. Our experts conduct these studies to find better treatments
  7. Dizziness
  8. Low white blood cell count: Infections
  9. Among them, 82 (0